Two compartment kinetic model with multiple artificial capillary units
- PMID: 3980324
- DOI: 10.1093/jac/15.suppl_a.131
Two compartment kinetic model with multiple artificial capillary units
Abstract
A two compartment in-vitro model was designed to simulate human pharmacokinetics and to expose bacterial cultures to changing drug concentrations, thereby avoiding limitations of conventional antibiotic testing at constant drug levels. Serially placed bacterial compartments, representing extravascular infection sites, interface with a central compartment through artificial capillaries. Drug concentrations within the culture chambers closely mimic interstitial concentrations in vivo. Simultaneous first order elimination kinetics of two drugs with different half-lives were simulated to study antibacterial effects of drug combinations. This in-vitro model is an efficient tool for optimal dosage regimen design and the study of synergistic/antagonistic effects of antibiotic combinations.
Similar articles
-
In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives.J Antimicrob Chemother. 1985 Jan;15 Suppl A:125-30. doi: 10.1093/jac/15.suppl_a.125. J Antimicrob Chemother. 1985. PMID: 3980323
-
In vitro models in the study of antibiotic therapy of infections in neutropenic patients.Am J Med. 1986 May 30;80(5C):40-4. Am J Med. 1986. PMID: 3717188
-
[In vitro model for the study of the concentration kinetics of antibiotic combinations and their antibacterial activity].Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Nov;262(4):512-21. Zentralbl Bakteriol Mikrobiol Hyg A. 1986. PMID: 3541460 German.
-
The use of pharmacokinetics in the design of fixed-ratio antibiotic combinations.G Ital Chemioter. 1979 Jan-Dec;26(1-2):407-12. G Ital Chemioter. 1979. PMID: 400152 Review. No abstract available.
-
Pharmacokinetics of antibiotics in tissues and tissue fluids: a review.Scand J Infect Dis Suppl. 1990;74:23-33. Scand J Infect Dis Suppl. 1990. PMID: 2097711 Review.
Cited by
-
The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.Antimicrob Agents Chemother. 2010 Jun;54(6):2646-54. doi: 10.1128/AAC.00065-10. Epub 2010 Apr 5. Antimicrob Agents Chemother. 2010. PMID: 20368395 Free PMC article.
-
Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic model.Antimicrob Agents Chemother. 2000 Mar;44(3):773-4. doi: 10.1128/AAC.44.3.773-774.2000. Antimicrob Agents Chemother. 2000. PMID: 10681356 Free PMC article.
-
SIMULTANEOUS IN VITRO SIMULATION OF MULTIPLE ANTIMICROBIAL AGENTS WITH DIFFERENT ELIMINATION HALF-LIVES IN A PRE-CLINICAL INFECTION MODEL.Comput Chem Eng. 2021 Dec;155:107540. doi: 10.1016/j.compchemeng.2021.107540. Epub 2021 Sep 13. Comput Chem Eng. 2021. PMID: 34924641 Free PMC article.
-
Model system to define pharmacokinetic requirements for antimalarial drug efficacy.Sci Transl Med. 2013 Oct 2;5(205):205ra135. doi: 10.1126/scitranslmed.3006684. Sci Transl Med. 2013. PMID: 24089407 Free PMC article.
-
Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2012 Dec;56(12):6137-46. doi: 10.1128/AAC.00851-12. Epub 2012 Sep 17. Antimicrob Agents Chemother. 2012. PMID: 22985878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical